Axis Momentum Fund
Regular Plan · IDCW Option · Axis Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +3.34% | +3.52% | 181 of 255 |
| 1M | +1.88% | +1.97% | 141 of 255 |
| 3M | -4.10% | -3.45% | 139 of 252 |
| 6M | -2.91% | +2.92% | 209 of 251 |
| YTD | -7.38% | +1.21% | 222 of 255 |
| 1Y | -7.29% | +1.11% | 202 of 232 |
| INCEPTION | -6.93% | — | — |
Ranked among: Equity Scheme - Sectoral/ Thematic.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +0.45% | +19.41% | -19.44% | 48% | 18% |
| 6M | +0.49% | +16.73% | -12.92% | 44% | 17% |
| 1Y | -0.73% | +15.09% | -13.25% | 37% | 13% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity89.98%
- Debt2.36%
- Cash-0.57%
- Other8.23%
Market Cap Split
- Large Cap24.73%
- Mid Cap27.16%
- Small Cap38.09%
- Others10.02%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 32.29 | 28.09 |
| P/B | 5.40 | 4.63 |
| Price / Sales | 3.88 | 3.31 |
| Price / Cash Flow | 30.25 | 21.08 |
| Dividend Yield (%) | 0.48 | 1.16 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| RBL Bank | Banks | 5.06% | +0.69% |
| PN Gadgil Jewellers | Consumer Durables | 4.98% | +0.47% |
| Laurus Labs | Pharmaceuticals & Biotechnology | 4.74% | +0.54% |
| Navin Fluorine International | Chemicals & Petrochemicals | 4.36% | +0.16% |
| Sai Life Sciences | Pharmaceuticals & Biotechnology | 4.08% | +0.51% |
| Federal Bank | Banks | 3.40% | -0.09% |
| Craftsman Automation | Auto Components | 3.24% | +0.05% |
| Radico Khaitan | Beverages | 3.11% | +0.18% |
| GMR Airports | Transport Infrastructure | 3.00% | +0.30% |
| BSE | Capital Markets | 3.00% | +0.09% |
| Aditya Birla Capital | Finance | 2.90% | +0.05% |
| Welspun Corp | Industrial Products | 2.75% | +0.93% |
| RR Kabel | Industrial Products | 2.69% | -0.18% |
| Syrma SGS | Industrial Manufacturing | 2.65% | +0.70% |
| Shriram Finance | Finance | 2.63% | -0.09% |
View all 48 holdings
| Karur Vysya Bank | Banks | 2.41% | +0.05% |
| Ather Energy | Automobiles | 2.37% | -0.24% |
| State Bank of India | Banks | 2.28% | -0.03% |
| Eternal | Retailing | 2.26% | +0.14% |
| CG Power & Industrial Solutions | Electrical Equipment | 2.23% | +0.04% |
| Max Healthcare Institute | Equity | 2.17% | -0.06% |
| Bharat Forge | Auto Components | 2.06% | +0.00% |
| Groww | Capital Markets | 1.64% | -0.45% |
| ICICI Bank | Banks | 1.57% | -0.01% |
| Cummins | Industrial Products | 1.41% | -1.37% |
| Reliance Industries | Petroleum Products | 1.41% | +0.02% |
| Kirloskar Oil Engines | Industrial Products | 1.37% | +0.23% |
| Bharti Airtel | Telecom - Services | 1.35% | +0.07% |
| KEI Industries | Industrial Products | 1.32% | -0.55% |
| Ashok Leyland | Agricultural, Commercial & Construction Vehicles | 1.28% | -0.06% |
| L&T Finance | Finance | 1.26% | -0.14% |
| Tata Motors | Agricultural, Commercial & Construction Vehicles | 1.25% | -0.03% |
| Cholamandalam Investment | Finance | 1.16% | -0.05% |
| Siemens | Electrical Equipment | 1.11% | +0.01% |
| Polycab | Industrial Products | 0.95% | -0.08% |
| Sobha | Realty | 0.92% | +0.05% |
| Prestige Estates Projects | Realty | 0.79% | -0.01% |
| Thyrocare Technologies | Equity | 0.76% | -0.03% |
| Clearing Corporation of India Ltd | Net Current Assets | 0.67% | — |
| 91TB151026 | Money Market | 0.59% | +0.05% |
| 364T231026 | Money Market | 0.59% | +0.05% |
| 91TB291026 | Money Market | 0.59% | +0.05% |
| 364T121126 | Money Market | 0.59% | +0.05% |
| Nykaa | Retailing | 0.57% | +0.00% |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.56% | +0.02% |
| ABB | Electrical Equipment | 0.48% | -0.02% |
| Metropolis Healthcare | Equity | 0.45% | +0.01% |
| Net Receivables / (Payables) | Net Current Assets | -1.24% | — |
Sector Allocation · Sep 2026
View all 19 sectors
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 16.55 | 16.32 | High Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.84 | -0.32 | Below Average |
| 3Y | -0.63 | -0.45 | Below Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.51 | 0.19 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Regular Plan · IDCW option
|
+59.64% | +47.37% | — | +23.17% |
|
HDFC Pharma and Healthcare Fund
Direct Plan · IDCW Option
|
+25.51% | +31.04% | — | +30.18% |
|
Kotak Healthcare Fund
Regular Plan · IDCW Option
|
+23.57% | — | — | +20.10% |
|
SBI Automotive Opportunities Fund
Direct Plan · IDCW
|
+22.37% | — | — | +11.34% |
|
Mirae Asset Healthcare Fund
Direct Plan · Growth
|
+21.28% | +24.36% | +16.89% | +22.00% |
|
ICICI Prudential US Bluechip Equity Fund
Regular Plan · IDCW
|
+20.32% | +18.33% | +12.09% | +15.77% |
|
PGIM India Healthcare Fund
Direct Plan · Direct IDCW
|
+20.03% | — | — | +11.89% |
|
Nippon India Japan Equity Fund
Regular Plan · Bonus Option
|
+18.89% | +19.86% | +8.28% | +8.45% |
|
HDFC Defence Fund
Regular Plan · IDCW Option
|
+18.80% | +34.56% | — | +36.67% |
|
HSBC India Export Opportunities Fund
Direct Plan · Growth
|
+18.74% | — | — | +9.24% |
More From Axis Asset Management Co. Ltd.
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Axis Silver ETF | +26.40% | +35.94% | — | +33.11% |
|
Axis Silver Fund of Fund
Direct Plan · Growth Option
|
+25.78% | +35.80% | — | +33.62% |
|
Axis Gold Fund
Direct Plan · Growth option
|
+16.88% | +30.78% | +23.12% | +10.32% |
| Axis Gold ETF | +16.64% | +30.81% | +23.30% | +11.67% |
|
Axis NASDAQ 100 US Specific Equity Passive FOF
Direct Plan · IDCW Option
|
+15.62% | +27.97% | — | +30.61% |
| Axis NIFTY Healthcare ETF | +13.26% | +21.08% | +14.40% | +13.81% |
|
Axis Global Equity Alpha Fund of Fund
Direct Plan · Growth Option
|
+13.25% | +22.73% | +13.92% | +16.86% |
|
Axis India Manufacturing Fund
Direct Plan · IDCW Option
|
+13.04% | — | — | +18.81% |
|
Axis Global Innovation Fund of Fund
Direct Plan · IDCW Option
|
+9.94% | +22.97% | +11.52% | +12.36% |
|
Axis Innovation Fund
Direct Plan · Growth Option
|
+9.66% | +17.73% | +10.46% | +14.81% |
About This Scheme
Investment Objective
The Scheme aims to provide long-term capital growth from an actively managed diversified portfolio of equity & equity-related securities of companies that exhibit strong momentum. The selection of securities will be based on a quantitative model that will aim to maximize momentum exposure based on various parameters. There is no assurance that the investment objective of the scheme will be achieved.
Stated Asset Allocation
Equity & Equity related instruments of companies selected based on momentum theme - 80%-100%, Other Equity and Equity related instruments - 0%-20%, Debt & Money Market Instruments - 0%-20%, Units issued by InVITs - 0%-10%
Exit Load
a). If redeemed / switched-out within 12 months from the date of allotment: For 10% of investments: NIL For remaining investments: 1% b). If redeemed / switched-out after 12 months from the date of allotment: NIL
Fund Managers
Mr. Nandik Mallik
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch